Related Experiment Video
Updated: Apr 21, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
Modulation of renin-angiotensin system and arterial stiffness: evidence from clinical trials
1Department of Cardiology Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gangdonggu, Seoul, 134-727, South Korea. issohn@khu.ac.kr.
Abstract:
Arterial stiffness has been recognized as an independent risk factor for cardiovascular morbidity and mortality in hypertension. The activity of the renin-angiotensin system(RAS) is well-known to be involved in the control of blood pressure, and pathogenesis and evolution of several cardiovascular diseases. Although data relating the RAS activity to arterial stiffness are incomplete, there is growing evidence which shows that drugs which interfere with angiotensin II reduce arterial stiffness. This brief review is to summarize the various effects of commonly used antihypertensive agents on arterial stiffness and to present clinical trials regarding RAS modulation in stiffness reduction.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure

